AbbVie (ABBV) RSU sell-vs-hold
Calculator · free · no signup · ABBVSell at vest or hold? Compare after-tax payout from selling AbbVie RSUs at vest vs. holding through the LTCG cliff at 12 months.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
Your vest
Tax inputs
Hold strategy
Best after-tax payout — at year 1 yr
$47,709
Sell + invest wins by $4,981 over Hold 1 yr.
Estimates only. Not financial advice.
Heads-up: under-withholding. Your employer withholds federal tax at the IRS supplemental rate (22.0% on this vest, ≈ $17,600). Your marginal federal rate on this vest is 32.7%, owing $26,171. Expect to settle the $8,571 gap at tax time.
The hidden purchase
Tax was paid at vest either way. Holding is mathematically equivalent to taking $44,509 in after-tax cash and buying $44,509 of ABBV today.
Most diversification frameworks would advise against a purchase that size in a single name; the right answer depends on your conviction in ABBV. Holding past one year converts the gain to LTCG.
Sell + invest
Best payout| Vest value (shares × price) | $80,000 |
| Federal | |
| State | |
| Medicare | −$1,160 |
| Additional Medicare | −$720 |
| Market gain over 1 yr at 10.0% | $4,451 |
| Cap-gain tax on diversified gain — LTCG (federal + state + NIIT) | −$1,251 |
| Net at year 1 yr | $47,709 |
Sell every share at vest; invest the after-tax cash at the market return for 1 yr, then liquidate. Diversified — no single-stock concentration risk.
Hold 1 yr
| Vest value (shares × price) | $80,000 |
| Vest tax (federal + state + FICA) | |
| Net at year 1 yr | $42,728 |
Sold 444 shares to cover vest tax (net-settled); kept 556 shares 1 yr to qualify for long-term capital gains.
Social Security + Medicare are payroll taxes (collectively called FICA) — they apply because you're still employed at vest.
Both columns are stated in year-1 yr dollars. The sell side compounds at the market return; the hold side compounds at your single-stock expected return after a 20% volatility drag.
Estimates only. Assumes net-settled (sell-to-cover) vesting; double-trigger and pre-IPO RSUs are out of scope. Excludes multi-state moves, AMT interactions on other equity, and 83(b) elections. Not financial advice.
You evaluated one RSU vest. The beta plans every vest of every grant across years, with concentration and AMT in the loop.
Request beta access →Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator
About AbbVie
AbbVie (ABBV) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in North Chicago, IL.
Last close: $261.59 per share (as of 2026-10-01).
Equity grants at AbbVie typically include restricted stock units (RSUs).
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Source: Wikipedia (CC BY-SA 4.0)
AbbVie separated from Abbott Laboratories on January 1, 2013, becoming an independent, publicly traded research-based pharmaceutical company headquartered in North Chicago, Illinois. It develops and markets prescription medicines in immunology (Skyrizi, Rinvoq), oncology, neuroscience, and aesthetics, the last added through its 2020 acquisition of Allergan (maker of Botox Cosmetic). The company employs roughly 55,000 people worldwide and grants equity compensation, including RSUs (restricted stock units, shares that vest over time) and stock options, as part of employee pay. AbbVie reported record full-year 2025 net revenue of $61.2 billion, up 8.5% operationally, with immunology products contributing $30.4 billion of that total.
Sources: sec.gov · investors.abbvie.com · en.wikipedia.org
Equity comp at AbbVie
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by AbbVie.
AbbVie (ABBV) RSUs vest as ordinary income at the price on vest day. The decision is whether to sell at vest and reinvest, or hold the shares through the 12-month LTCG cliff. This calculator runs both paths through the same after-tax math so you can compare like-for-like.
Example: 500 AbbVie (ABBV) RSUs vesting at $261.59 per share is $130,795 of ordinary income on vest day. After roughly 32% combined federal + state + FICA (~$41,854), the post-tax share value is ~$88,941. Holding 12 months for long-term capital-gains treatment then only matters for the price change between vest and sale; the ordinary income at vest is already locked in. The calculator runs both paths through the same after-tax math.
All AbbVie tools → · Use the generic RSU Sell-vs-Hold Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →
AbbVie equity questions
- Should I sell or hold my AbbVie RSUs at vest?
- AbbVie restricted stock units (RSUs) are taxed as ordinary income on their value at vest whether or not you sell. The only open decision is what to do with the shares afterward: sell at vest and reinvest, or hold past twelve months for long-term capital-gains treatment on any further gain. The calculator above runs both paths through the same after-tax math so you can compare them directly.
- Does AbbVie grant ISOs, NSOs, or RSUs?
- Equity compensation at AbbVie typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do AbbVie RSUs use double-trigger vesting?
- No. AbbVie restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your AbbVie equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.